A prospective evaluation of opioid weaning in opioid-dependent pediatric critical care patients

Richard J Berens1, Michael T Meyer, Theresa A Mikhailov

  • 1Department of Anesthesiology, Medical College of Wisconsin, Children's Hospital of Wisconsin, USA. rberens@chw.org

Insights

Opioid-dependent critically ill children can be weaned off medication in 5 days using oral methadone, showing no increased risk of withdrawal symptoms compared to a 10-day wean. This study offers a faster approach to opioid weaning in pediatric intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Neonatal abstinence syndrome

Background:

  • Critically ill children often receive opioid medication for pain and stress management.
  • Prolonged opioid use in pediatric intensive care units (PICU) can lead to opioid dependency.
  • Abrupt cessation of opioids in dependent children can precipitate a withdrawal syndrome.

Purpose of the Study:

  • To compare the efficacy of a 5-day versus a 10-day oral methadone weaning protocol for opioid-dependent children in the PICU.
  • To assess the incidence of opioid withdrawal events requiring rescue medication in both weaning groups.

Main Methods:

  • A prospective, randomized trial was conducted with opioid-dependent children.
  • Participants were assigned to either a 5-day or a 10-day oral methadone weaning schedule.
  • Opioid withdrawal was monitored using neonatal abstinence scores, with rescue medication administered for scores exceeding a defined threshold.

Main Results:

  • No significant difference in the number of agitation events requiring opioid rescue was observed between the 5-day and 10-day weaning groups.
  • The majority of rescue events occurred around days 5 and 6 of the weaning process in both groups.
  • Children had an average opioid exposure of 3 weeks prior to enrollment.

Conclusions:

  • A 5-day oral methadone weaning protocol appears feasible for opioid-dependent children in the PICU.
  • This shorter weaning duration did not result in an increased incidence of withdrawal events requiring rescue.
  • Further follow-up is recommended to monitor for potential delayed withdrawal syndromes after medication cessation.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...